Pharmafile Logo
Pharmafocus logo
Advanced Search

New product launches – maximise your chance of success

September 6, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing MSI, Paul Stuart Kregor, Paul Stuart-Kregor, marketing, product launch

You don’t have to look very far to see that the pharma industry business model is under increased pressure, and …

Feature

Brazil delays excipient GMP deadline

September 6, 2012
Manufacturing and Production ANVISA, Brazil, GMP

Brazil’s national medicines regulatory agency ANVISA has delayed proposed new rules on good manufacturing practice (GMP) for pharmaceutical excipients after …

News

Hospira buys Indian antibiotic plant

September 6, 2012
Manufacturing and Production Hospira, India

US injectable drugs specialist Hospira has announced plans to expand in India via the purchase of a manufacturing facility and …

News
fda_sign_web

Double approval for Pfizer cancer drugs

September 6, 2012
Sales and Marketing CML, Cancer, Glivec, Pfizer, axitinib, rcc

 Two cancer drugs from Pfizer have been approved, one in Europe for kidney cancer and another in the US for …

News

Merck KGaA cuts over 10% of German workforce

September 5, 2012
Research and Development

Merck KGaA is to get rid of more than 10% of its workforce in Germany over the next three years …

News

Pharma welcomes Hunt to top health job

September 5, 2012
Research and Development, Sales and Marketing Andrew Lansley, NHS, NHS reform

The ABPI has used health secretary Andrew Lansley’s demotion at prime minister David Cameron’s first major cabinet reshuffle to restate …

News

Pfizer to develop phase II cancer vaccine

September 4, 2012
Research and Development, Sales and Marketing Cancer, Pfizer, VLST, cancer vaccine

Pfizer has licensed a cancer compound which is ready for phase II study from a US firm specialising in cancer …

News

Valeant to buy dermatogy firm Medicis

September 4, 2012
Sales and Marketing Valeant

Speciality pharma company Valeant is to acquire dermatology-focused Medicis for $2.6 billion.Medicis’ portfolio includes ‘cosmaceutical’ prescription brands such as Solodyn, …

News

Contract research news in brief

September 4, 2012
Research and Development CRO, Charles River, WuXi

 Charles River Laboratories (CRL) has paid $17 million for Accugenix, a company which provides endotoxin detection and microbial identity testing …

News

Genzyme recalls drug on failed stability testing

September 4, 2012
Manufacturing and Production Genzyme, Stability Testing, pharma recalls

Sanofi subsidiary Genzyme has recalled nine lots of its transplant drug Thymoglobulin in the US after stability testing revealed there …

News

Cash incentive for NHS digital info sharing

September 3, 2012
NHS, digital

NHS bodies which develop new digital services for sharing information could be eligible for thousands of pounds worth of funding, …

News

Cash incentive for NHS digital info sharing

September 3, 2012
NHS, digital

NHS bodies which develop new digital services for sharing information could be eligible for thousands of pounds worth of funding, …

News
Novartis

Novartis cheered by COPD trial results

September 3, 2012
Research and Development COPD, ERS, Novartis

One of Novartis’ experimental respiratory drugs has proved superior in a late-stage trial to Boehringer Ingelheim and Pfizer’s existing brand …

News
db3

The ex-CEO’s Job Blog – part 1

September 3, 2012
Medical Communications David Barratt, Jobs, careers, pharma jobs, restructuring, the ex-CEO's job blog

I have seen a lot in my healthcare career. Been round the block more than twice, as they say. I …

Feature

New quad HIV pill passed by FDA

September 2, 2012
Sales and Marketing FDA, Gilead, HIV, stribild

Gilead’s four-in-one anti-HIV once-daily pill Stribild has been given the green light by the FDA for adults who have not …

News

J&J buys into Genmab cancer drug

August 31, 2012
Sales and Marketing Cancer, Genmab, Janssen Cilag, Janssen-Cilag, Johnson & Johnson, multiple myeloma

Danish biotech company Genmab has sold the worldwide rights for one of its cancer drugs to Johnson & Johnson-owned Janssen …

News
GSK Stevenage

ABPI worried by public ignorance about medicines

August 31, 2012
Sales and Marketing ABPI, UK

People in the UK are misinformed about how much medicines cost to discover, develop and launch, according to a new …

News

Publicis creates new digital agency Razorfish Healthware

August 31, 2012
Medical Communications Razorfish Healthware, advertising, digital, publicis

 Two Publicis agencies, Razorfish Health and Publicis Healthware International are to be merged to create Razorfish Healthware, which will focus …

News

CPC Healthcare joins Indigenus network

August 31, 2012
Medical Communications CPC Healthcare Communications, CementBloc, Indegenus, Indigenus

CPC Healthcare Communications, based in Toronto, Canada, has joined Indigenus, the global network of independent healthcare agencies.The Indigenus network spans …

News

Patient death halts BMS hep C trial

August 30, 2012
Sales and Marketing BMS, HCV, hepatitis C

Bristol-Myers Squibb has admitted that the death of a patient was behind its decision to stop development of a potential …

News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026